Manal Adly Alsayed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Manal Adly Alsayed has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Shaimaa Selmi Sobieh
Botany Department, Faculty of Women for Arts, Science and Education, Ain Shams University, Cairo, Egypt
2 shared publications - Soad Ahmed Abdallah
Ain Shams University
2 shared publications - Shereen A. H. Mohamed
Microbial Genetics Department, National Research Centre, Cairo 11511, Egypt
1 shared publication - Shereen Abdel-Hameed Mohamed
Microbial Genetics Department, National Research Centre, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 1 October 2023
- Published by Egyptian Knowledge Bank in Miṣriqiyā
- Vol. 3 (2) , 1-9
Phenotypic Screening of Multidrug-resistance (MDR) Acinetobacter baumannii from public hospitals in Egypt
Multidrug-resistance (MDR) is a major and an on-going public health problem globally. It occurs mainly among Gram-negative pathogens of Enterobacteriaceae such as Klebsiella pneumoniae, Pseudomonas aeruginosa and recently observed in Acinetobacter baumannii, Acinetobacter baumannii are Gram-negative opportunistic bacteria with low virulence properties. Their resistance to antibiotics has become a problem of concern in hospital infections and one of the pathogens responsible for healthcare associated infections (nosocomial). A total of 117 clinical samples of Acinetobacter spp. were collected through anonymous sources from the clinical microbiology laboratory and compartment or inanimate objects, and they were identified phenotypically 78 isolates were detected phenotypically as A.baumannii and 47/78 isolates (59.7%) were detected as MDR A.baumannii. This type of resistance are already widespread in certain parts of the world, particularly Europe, Asia and South America, while the situation in other places such as Africa is not well documented. This study aimed to investigate the multi-drug resistance profile of A.baumannii from different infection sites, and it’s spreading in Egypt.
- 1 October 2023
- Published by Egyptian Knowledge Bank in Miṣriqiyā
- Vol. 3 (2) , 1-9
Open AccessPhenotypic Screening of Multidrug-resistance (MDR) Acinetobacter baumannii from public hospitals in Egypt
Multidrug-resistance (MDR) is a major and an on-going public health problem globally. It occurs mainly among Gram-negative pathogens of Enterobacteriaceae such as Klebsiella pneumoniae, Pseudomonas aeruginosa and recently observed in Acinetobacter baumannii, Acinetobacter baumannii are Gram-negative opportunistic bacteria with low virulence properties. Their resistance to antibiotics has become a problem of concern in hospital infections and one of the pathogens responsible for healthcare associated infections (nosocomial). A total of 117 clinical samples of Acinetobacter spp. were collected through anonymous sources from the clinical microbiology laboratory and compartment or inanimate objects, and they were identified phenotypically 78 isolates were detected phenotypically as A.baumannii and 47/78 isolates (59.7%) were detected as MDR A.baumannii. This type of resistance are already widespread in certain parts of the world, particularly Europe, Asia and South America, while the situation in other places such as Africa is not well documented. This study aimed to investigate the multi-drug resistance profile of A.baumannii from different infection sites, and it’s spreading in Egypt.
- Open Access
- 30 August 2023
- Published by MDPI AG in Microbiology Research
- Vol. 14 (3) , 1238-1251
Molecular Assessment of MCR-1 Gene among Pandrug-Resistant Acinetobacter baumannii
Background Antimicrobial resistance has become one of the most widespread threats to humans. Acinetobacter baumannii is one of the pathogens responsible for healthcare-associated infections (nosocomial). Colistin is considered the last resort antibiotic against infections with pandrug-resistant (PDR) pathogens. Results: Eleven isolates were detected phenotypically as PDR A. baumannii and were confirmed molecularly using 16S rDNA. The MCR-1 gene was not detected within the chromosomal DNA of the selected isolates. Plasmid bearing the MCR-1 gene was identified in 10 selected isolates of A. baumannii that had not been previously observed to carry the MCR-1 gene. Moreover, the use of colistin in combination with anionic antibiotics or natural compound pterostilbene poses a viable therapeutic alternative for PDR and revives colistin’s bactericidal effects on MCR-1-positive A. baumannii. Finally, the transmission electron microscopy studies proved the synergistic effect of these combinations and revealed the disruption of resistant A. baumannii’s outer membrane and alteration of the permeability properties that allowed overcoming the resistance of the isolates to colistin. Conclusions: Antimicrobial resistance of A. baumannii is related to the presence of the transferable plasmid-bearing MCR-1 gene. This study proved the ability of the combinations of colistin with anionic antibiotics and/or natural compound pterostilbene to restore the bactericidal effect of colistin. Overall, these combinations could be novel promising clinical alternatives against the increasing threat of the widespread multidrug-resistant A. baumannii.
- 30 August 2023
- Published by MDPI AG in Microbiology Research
- Vol. 14 (3) , 1238-1251
Open AccessMolecular Assessment of MCR-1 Gene among Pandrug-Resistant Acinetobacter baumannii
Background Antimicrobial resistance has become one of the most widespread threats to humans. Acinetobacter baumannii is one of the pathogens responsible for healthcare-associated infections (nosocomial). Colistin is considered the last resort antibiotic against infections with pandrug-resistant (PDR) pathogens. Results: Eleven isolates were detected phenotypically as PDR A. baumannii and were confirmed molecularly using 16S rDNA. The MCR-1 gene was not detected within the chromosomal DNA of the selected isolates. Plasmid bearing the MCR-1 gene was identified in 10 selected isolates of A. baumannii that had not been previously observed to carry the MCR-1 gene. Moreover, the use of colistin in combination with anionic antibiotics or natural compound pterostilbene poses a viable therapeutic alternative for PDR and revives colistin’s bactericidal effects on MCR-1-positive A. baumannii. Finally, the transmission electron microscopy studies proved the synergistic effect of these combinations and revealed the disruption of resistant A. baumannii’s outer membrane and alteration of the permeability properties that allowed overcoming the resistance of the isolates to colistin. Conclusions: Antimicrobial resistance of A. baumannii is related to the presence of the transferable plasmid-bearing MCR-1 gene. This study proved the ability of the combinations of colistin with anionic antibiotics and/or natural compound pterostilbene to restore the bactericidal effect of colistin. Overall, these combinations could be novel promising clinical alternatives against the increasing threat of the widespread multidrug-resistant A. baumannii.